Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease

Neuroscience

Volumn 122, Issue 2, 2003, Pages 515-520

  Mousavi, M ^a   Hellstrom Lindahl E ^a   Guan, Z Z ^a   Shan, K R ^a   Ravid, R ^b   Nordberg, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Alzheimer's disease; Human; Nicotine; Postmortem; RT PCR; Western blotting

Indexed keywords

BRAIN PROTEIN; BRAIN RECEPTOR; CHOLINERGIC RECEPTOR; MESSENGER RNA; NICOTINIC RECEPTOR; PROTEIN SUBUNIT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; TEMPORAL CORTEX; TOBACCO DEPENDENCE; UPREGULATION; WESTERN BLOTTING;

EID: 0242486453     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00460-3     Document Type: Article

References (34)

1. Bencherif M., Fowler K., Lukas R.J., Lippiello P.M. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther. 275:1995;987-994.
2. 3H]nicotine binding sites in human brain. J Neurochem. 50:1988;1243-1247.
3. Braak H., Braak E. Evolution of neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl. 165:1996;3-12.
4. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther. 282:1997;7-13.
5. Court J., Martin-Ruiz C., Piggott M., Spurden D., Griffiths M., Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry. 49:2001;175-184.
6. Court J.A., Lloyd S., Thomas N., Piggott M.A., Marshall E.F., Morris C.M., Lamb H., Perry R.H., Johnson M., Perry E.K. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience. 87:1998;63-78.
7. Decker M.W., Majchrzak M.J., Anderson D.J. Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res. 572:1992;281-285.
8. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol. 41:1992;31-37.
9. Guan Z.Z., Zhang X., Blennow K., Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 10:1999;1779-1782.
10. Guan Z.Z., Zhang X., Ravid R., Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem. 74:2000;237-243.
11. Hellström-Lindahl E., Gorbounova O., Seiger A., Mousavi M., Nordberg A. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res. 108:1998;147-160.
12. Hellström-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain comparison between Alzheimer and normal brain . Brain Res Mol Brain Res. 66:1999;94-103.
13. Jones G.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology. 108:1992;485-494.
14. Lee P.N. Smoking and Alzheimer's disease a review of the epidemiological evidence . Neuroepidemiology. 13:1994;131-144.
15. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., Collins A.C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci. 12:1992;2765-2784.
16. Martin-Ruiz C.M., Court J.A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem. 73:1999;1635-1640.
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
18. Merchant C., Tang M.X., Albert S., Manly J., Stern Y., Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology. 52:1999;1408-1412.
19. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease . Neurology. 41:1991;479-486.
20. Mousavi M., Hellström-Lindahl E., Guan Z.Z., Bednar I., Nordberg A. Expression of nicotinic acetylcholine receptors in human and rat adrenal medulla. Life Sci. 70:2001;577-590.
21. Newhouse P.A., Kelton M. Nicotinic systems in central nervous systems disease degenerative disorders and beyond . Pharm Acta Helv. 74:2000;91-101.
22. Newhouse P.A., Potter A., Corwin J., Lenox R. Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology. 108:1992;480-484.
23. Newhouse P.A., Potter A., Kelton M., Corwin J. Nicotinic treatment of Alzheimer's disease. Biol Psychiatry. 49:2001;268-278.
24. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease therapeutic implications . Biol Psychiatry. 49:2001;200-210.
25. Ott A., Slooter A.J., Hofman A., van Harskamp F., Witteman J.C., Van Broeckhoven C., van Duijn C.M., Breteler M.M. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study the Rotterdam Study . Lancet. 351:1998;1840-1843.
26. Paterson D., Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol. 61:2000;75-111.
27. Pauly J.R., Marks M.J., Gross S.D., Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther. 258:1991;1127-1136.
28. Peng X., Gerzanich V., Anand R., Whiting P.J., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol. 46:1994;523-530.
29. Perry D.C., Davila-Garcia M.I., Stockmeier C.A., Kellar K.J. Increased nicotinic receptors in brains from smokers membrane binding and autoradiography studies . J Pharmacol Exp Ther. 289:1999;1545-1552.
30. Rowell P.P., Li M. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem. 68:1997;1982-1989.
31. Sargent P. The distribution of neuronal nicotinic acetylcholine receptors. Clementi F., Fornasari D., Gotti C. Handbook of experimental pharmacology. 2000;163-192 Spring-Verlag, Berlin.
32. Warpman U., Friberg L., Gillespie A., Hellstrom-Lindahl E., Zhang X., Nordberg A. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells. J Neurochem. 70:1998;2028-2037.
33. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci. 11:1990;216-219.
34. Zhang X., Gong Z.H., Hellstrom-Lindahl E., Nordberg A. Regulation of alpha 4 beta 2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. Neuroreport. 6:1995;313-317.